Stay updated on Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial

Sign up to get notified when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to reflect new study objectives and details regarding the incidence of breast and bladder cancer among patients using dapagliflozin. Additionally, the study's recruitment status has changed, and the number of study locations has been adjusted.
    Difference
    14%
    Check dated 2025-02-24T20:35:06.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:48:21.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T07:53:24.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T22:35:53.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    0.3%
    Check dated 2025-01-12T18:12:13.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T22:46:20.000Z thumbnail image

Stay in the know with updates to Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.